First report in Spain of linezolid non-susceptibility in a clinical isolate of Staphylococcus haemolyticus

International Journal of Antimicrobial Agents

Volumn 30, Issue 3, 2007, Pages 277-278

  Tarazona, Raquel Elisa Rodríguez ^a   Padilla, Trinidad Parras ^a   Gómez, Juan Carlos Sánchez ^a   Sánchez, José Elías García ^a   Hernandez, Manuel Sánchez ^b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFAZOLIN; CEFOTAXIME; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DNA FRAGMENT; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; OXACILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; RIBOSOME RNA; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CASE REPORT; DRUG MECHANISM; GENE MUTATION; GENOTYPE; GUNSHOT INJURY; HUMAN; INTRAVENOUS CATHETER; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RNA GENE; SPAIN; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS SIMULANS; THORAX INJURY; WOUND INFECTION;

ACETAMIDES; ADULT; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; SPAIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS HAEMOLYTICUS; WOUND INFECTION; WOUNDS, GUNSHOT;

EID: 34547212373     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.04.010     Document Type: Letter

References (8)

1. Bozdogan B., and Appelbaum P.C. Oxazolidinones: activity, mode of action, and mechanism of resistance. Int J Antimicrob Agents 23 (2004) 113-119
2. Meka V.G., Pillai S.K., Sakoulas G., et al. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA. J Infect Dis 190 (2004) 311-317
3. Marshall S.H., Donskey C.J., Hutton-Thomas R., Salata R.A., and Rice L.B. Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother 46 (2002) 3334-3336
4. Tsiodras S., Gold H.S., Sakoulas G., et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358 (2001) 207-208
5. Baysallar M., Kilic A., Aydogan H., Cilli F., and Doganci L. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey. Int J Antimicrob Agents 23 (2004) 510-512
6. Maki D.G., Weise C.E., and Sarafin H.W. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 296 (1977) 1305-1309
7. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Document M100-S16. Wayne, PA: NCCLS; 2006.
8. John M.A., Pletch C., and Hussain Z. In vitro activity of quinupristin/dalfopristin, linezolid, telithromycin and comparator antimicrobial agents against 13 species of coagulase-negative staphylococci. J Antimicrob Agents 50 (2002) 933-938